Skip to main content
SpringerLink
Log in

Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Background

Opioid neurotransmission mediates hedonic value of sweet tastants; their intake may be exaggerated by the consumption of exogenous opioids (e.g., opioid dependence). Sweet Taste Test (STT) is a validated quantitative instrument assessing taste perception and hedonic features of sugar (sucrose) using a randomized and double-blind administration at five different sucrose concentrations ranging from 0.05 to 0.83 M.

Methods

The STT and cue-induced craving procedure were administered to opioid-dependent patients (n = 15) before and 1 week after the injection of a long-acting depot naltrexone (XRNT) preparation.

Results

Analyses of covariance, employing sucrose concentration and its perceived taste as covariates, showed that XRNT therapy significantly reduced the self-reported hedonic and motivational characteristics of sucrose. Greater reductions in both these characteristics were associated with more diminution in the cue-induced opioid craving.

Conclusions

Opioid antagonism in opioid-dependent subjects leads to a smaller sweet taste reward, which, in turn, may be proportional to decreased opioid craving. These pilot results support the heuristic value of the STT as a potential marker of the XRNT treatment response and call for further inquiry into potential clinical applications of the test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Arbisi PA, Billington CJ, Levine AS (1999) The effect of naltrexone on taste detection and recognition threshold. Appetite 32:241–249

    Article  PubMed  CAS  Google Scholar 

  • Berridge KC (2007) The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl) 191:391–431

    Article  CAS  Google Scholar 

  • Berridge KC, Robinson TE (2003) Parsing reward. Trends Neurosci 26:507–513

    Article  PubMed  CAS  Google Scholar 

  • Berridge KC, Robinson TE, Aldridge JW (2009) Dissecting components of reward: ‘liking’, ‘wanting’, and learning. Curr Opin Pharmacol 9:65–73

    Article  PubMed  CAS  Google Scholar 

  • Berthoud HR (2003) Neural systems controlling food intake and energy balance in the modern world. Curr Opin Clin Nutr Metab Care 6:615–620

    Article  PubMed  CAS  Google Scholar 

  • Carr KD (2002) Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms. Physiol Behav 76:353–364

    Article  PubMed  CAS  Google Scholar 

  • Childress AR, McLellan AT, O'Brien CP (1986) Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction. Br J Addict 81:655–660

    Article  PubMed  CAS  Google Scholar 

  • Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11–18

    PubMed  CAS  Google Scholar 

  • Cicero TJ, Ennis T, Ogden J, Meyer ER (2000) Gender differences in the reinforcing properties of morphine. Pharmacol Biochem Behav 65:91–96

    Article  PubMed  CAS  Google Scholar 

  • Cicero TJ, Aylward SC, Meyer ER (2003) Gender differences in the intravenous self-administration of mu opiate agonists. Pharmacol Biochem Behav 74:541–549

    Article  PubMed  CAS  Google Scholar 

  • Cornish JW, Metzger D, Woody GE, Wilson D, McLellan AT, Vandergrift B, O'Brien CP (1997) Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 14:529–534

    Article  PubMed  CAS  Google Scholar 

  • de Vos JW, Geerlings PJ, van den Brink W, Ufkes JG, van Wilgenburg H (1995) Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts. Eur J Clin Pharmacol 48:361–366

    Article  PubMed  Google Scholar 

  • Elman I, Karlsgodt KH, Gastfriend DR, Chabris CF, Breiter HC (2002) Cocaine-primed craving and its relationship to depressive symptomatology in individuals with cocaine dependence. J Psychopharmacol 16(2):163–167

    Google Scholar 

  • Elman I, Ariely D, Mazar N, Aharon I, Lasko NB, Macklin ML, Orr SP, Lukas SE, Pitman RK (2005) Probing reward function in post-traumatic stress disorder with beautiful facial images. Psychiatry Res 135:179–183

    Article  PubMed  Google Scholar 

  • Elman I, Borsook D, Lukas SE (2006) Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology 31:2091–2120

    Article  PubMed  CAS  Google Scholar 

  • Fattore L, Altea S, Fratta W (2008) Sex differences in drug addiction: a review of animal and human studies. Womens Health (Lond Engl) 4:51–65

    Article  CAS  Google Scholar 

  • First M (2002) Diagnostic and statistical manual of mental disorders. Text revision, 4th edn. American Psychiatric Association, Washington

    Google Scholar 

  • Garbutt JC, Osborne M, Gallop R, Barkenbus J, Grace K, Cody M, Flannery B, Kampov-Polevoy AB (2009) Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence. Alcohol Alcohol 44:293–300

    PubMed  CAS  Google Scholar 

  • Grella CE, Lovinger K (2011) 30-year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California. Drug and Alcohol Depend. doi:10.1016/j.drugalcdep.2011.04.004

  • Grigson PS (2002) Like drugs for chocolate: separate rewards modulated by common mechanisms? Physiol Behav 76:389–395

    Article  PubMed  CAS  Google Scholar 

  • Hillemacher T, Heberlein A, Muschler MA, Bleich S, Frieling H (2011) Opioid modulators for alcohol dependence. Expert Opin Investig Drugs 20(8):1073–1086

    Article  PubMed  CAS  Google Scholar 

  • Hulse GK, Morris N, Arnold-Reed D, Tait RJ (2009) Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone. Arch Gen Psychiatry 66:1108–1115

    Article  PubMed  Google Scholar 

  • Kampov-Polevoy A, Garbutt JC, Janowsky D (1997) Evidence of preference for a high-concentration sucrose solution in alcoholic men. Am J Psychiatry 154:269–270

    PubMed  CAS  Google Scholar 

  • Kampov-Polevoy AB, Eick C, Boland G, Khalitov E, Crews FT (2004) Sweet liking, novelty seeking, and gender predict alcoholic status. Alcohol Clin Exp Res 28:1291–1298

    Article  PubMed  Google Scholar 

  • Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, Zhang M (2002) Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 76:365–377

    Article  PubMed  CAS  Google Scholar 

  • Kelly SM, Schwartz RP, O'Grady KE, Mitchell SG, Reisinger HS, Peterson JA, Agar MH, Brown BS (2009) Gender differences among in- and out-of-treatment opioid-addicted individuals. Am J Drug Alcohol Abuse 35:38–42

    Article  PubMed  Google Scholar 

  • King A, Cao D, Vanier C, Wilcox T (2009) Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study. Alcohol Clin Exp Res 33:1044–1050

    Article  PubMed  CAS  Google Scholar 

  • Krupitsky EM, Blokhina EA (2010) Long-acting depot formulations of naltrexone for heroin dependence: a review. Curr Opin Psychiatry 23(3):210–214

    Article  PubMed  Google Scholar 

  • Laaksonen E, Lahti J, Sinclair JD, Heinala P, Alho H (2011) Predictors for the efficacy of naltrexone treatment in alcohol dependence: sweet preference. Alcohol Alcohol 46:308–311

    PubMed  CAS  Google Scholar 

  • Langleben DD, Ruparel K, Elman I, Busch-Winokur S, Pratiwadi R, Loughead J, O'Brien CP, Childress AR (2008) Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry 165:390–394

    Article  PubMed  Google Scholar 

  • Lobmaier P, Kornor H, Kunoe N, Bjorndal A (2008) Sustained-release naltrexone for opioid dependence. Cochrane Database Syst Rev. CD006140

  • Lobmaier PP, Kunoe N, Gossop M, Katevoll T, Waal H (2010) Naltrexone implants compared to methadone: outcomes six months after prison release. Eur Addict Res 16:139–145

    Article  PubMed  Google Scholar 

  • McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M (1992) The fifth edition of the Addiction Severity Index. J Subst Abus Treat 9:199–213

    Article  CAS  Google Scholar 

  • Mihindou C, Vouillac C, Koob GF, Ahmed SH (2011) Preclinical validation of a novel cocaine exposure therapy for relapse prevention. Biol Psychiatry 70(6):593–598

    Article  PubMed  CAS  Google Scholar 

  • Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K (2008) Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry 65:466–475

    Article  PubMed  CAS  Google Scholar 

  • Nolan LJ, Scagnelli LM (2007) Preference for sweet foods and higher body mass index in patients being treated in long-term methadone maintenance. Subst Use Misuse 42:1555–1566

    Article  PubMed  Google Scholar 

  • Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546–1552

    Article  PubMed  CAS  Google Scholar 

  • Paronis CA, Bergman J (2011) Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal. J Pharmacol Exp Ther 336:488–495

    Article  PubMed  CAS  Google Scholar 

  • Pecina S, Smith KS (2010) Hedonic and motivational roles of opioids in food reward: implications for overeating disorders. Pharmacol Biochem Behav 97:34–46

    Article  PubMed  CAS  Google Scholar 

  • Pecina S, Cagniard B, Berridge KC, Aldridge JW, Zhuang X (2003) Hyperdopaminergic mutant mice have higher “wanting” but not “liking” for sweet rewards. J Neurosci 23:9395–9402

    PubMed  CAS  Google Scholar 

  • Puigdollers E, Domingo-Salvany A, Brugal MT, Torrens M, Alvaros J, Castillo C, Magri N, Martin S, Vazquez JM (2004) Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Subst Use Misuse 39:1353–1368

    Article  PubMed  Google Scholar 

  • Ruan X, Chen T, Gudin J, Couch JP, Chiravuri S (2010) Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literature. J Opioid Manag 6:300–303

    Article  PubMed  Google Scholar 

  • Sadava D, Alonso D, Hong H, Pettit-Barrett DP (1997) Effect of methadone addiction on glucose metabolism in rats. Gen Pharmacol 28:27–29

    Article  PubMed  CAS  Google Scholar 

  • Shin AC, Pistell PJ, Phifer CB, Berthoud HR (2010) Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens. Neuroscience 170:580–588

    Article  PubMed  CAS  Google Scholar 

  • Smeets PA, de Graaf C, Stafleu A, van Osch MJ, van der Grond J (2005) Functional magnetic resonance imaging of human hypothalamic responses to sweet taste and calories. Am J Clin Nutr 82:1011–1016

    PubMed  CAS  Google Scholar 

  • Spetter MS, Smeets PA, de Graaf C, Viergever MA (2010) Representation of sweet and salty taste intensity in the brain. Chem Senses 35:831–840

    Article  PubMed  CAS  Google Scholar 

  • Stromberg MF, Meister S, Volpicelli JR, Ulm RR (1997) Morphine enhances selection of both sucrose and ethanol in a two-bottle test. Alcohol 14:55–62

    Article  PubMed  CAS  Google Scholar 

  • Ward AS, Collins ED, Haney M, Foltin RW, Fischman MW (1999) Blockade of cocaine-induced increases in adrenocorticotrophic hormone and cortisol does not attenuate the subjective effects of smoked cocaine in humans. Behav Pharmacol 10(5):523–529

    Google Scholar 

  • Will MJ, Franzblau EB, Kelley AE (2004) The amygdala is critical for opioid-mediated binge eating of fat. Neuroreport 15:1857–1860

    Article  PubMed  CAS  Google Scholar 

  • Wilson SJ, Sayette MA, Fiez JA (2004) Prefrontal responses to drug cues: a neurocognitive analysis. Nat Neurosci 7:211–214

    Article  PubMed  Google Scholar 

  • Yu J, Zhang S, Epstein DH, Fang Y, Shi J, Qin H, Yao S, Le Foll B, Lu L (2007) Gender and stimulus difference in cue-induced responses in abstinent heroin users. Pharmacol Biochem Behav 86(3):485–492

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

    Daniel D. Langleben, Elliot L. Busch & Charles P. O’Brien

  2. Philadelphia Veterans Administration Medical Center, Philadelphia, PA, USA

    Daniel D. Langleben

  3. Bedford Veterans Administration Medical Center, Bedford, MA, USA

    Igor Elman

  4. Department of Psychiatry, Cambridge Health Alliance, Harvard Medical School, Boston, MA, USA

    Igor Elman

Authors
  1. Daniel D. Langleben
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elliot L. Busch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charles P. O’Brien
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Igor Elman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel D. Langleben.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Langleben, D.D., Busch, E.L., O’Brien, C.P. et al. Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence. Psychopharmacology 220, 559–564 (2012). https://doi.org/10.1007/s00213-011-2503-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-011-2503-1

Keywords

Search

Navigation